Pudumjee Paper Products Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 29, 2025, 11:27 am

Competitors of Pudumjee Paper Products Ltd

All Competitor Stocks of Pudumjee Paper Products Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:02 am

Below is a detailed analysis of the quarterly data for Pudumjee Paper Products Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 190.00 Cr.. The value appears to be declining and may need further review. It has decreased from 194.00 Cr. (Dec 2024) to 190.00 Cr., marking a decrease of 4.00 Cr..
• For Expenses, as of Mar 2025, the value is 166.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 168.00 Cr. (Dec 2024) to 166.00 Cr., marking a decrease of 2.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Dec 2024) to 24.00 Cr., marking a decrease of 2.00 Cr..
• For OPM %, as of Mar 2025, the value is 13.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 13.00%.
• For Other Income, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 5.00 Cr..
• For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 3.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Dec 2024) to 25.00 Cr., marking a decrease of 2.00 Cr..
• For Tax %, as of Mar 2025, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Dec 2024) to 24.00%, marking a decrease of 4.00%.
• For Net Profit, as of Mar 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Dec 2024) to 19.00 Cr., marking a decrease of 1.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 1.99. The value appears to be declining and may need further review. It has decreased from 2.06 (Dec 2024) to 1.99, marking a decrease of 0.07.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:23 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:29 am

Below is a detailed analysis of the balance sheet data for Pudumjee Paper Products Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
• For Reserves, as of Mar 2025, the value is 573.00 Cr.. The value appears strong and on an upward trend. It has increased from 483.00 Cr. (Mar 2024) to 573.00 Cr., marking an increase of 90.00 Cr..
• For Borrowings, as of Mar 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 22.00 Cr. (Mar 2024) to 12.00 Cr., marking a decrease of 10.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 168.00 Cr.. The value appears to be improving (decreasing). It has decreased from 200.00 Cr. (Mar 2024) to 168.00 Cr., marking a decrease of 32.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 763.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 715.00 Cr. (Mar 2024) to 763.00 Cr., marking an increase of 48.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 276.00 Cr.. The value appears strong and on an upward trend. It has increased from 272.00 Cr. (Mar 2024) to 276.00 Cr., marking an increase of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2024) to 28.00 Cr., marking an increase of 8.00 Cr..
• For Investments, as of Mar 2025, the value is 150.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 150.00 Cr..
• For Other Assets, as of Mar 2025, the value is 310.00 Cr.. The value appears strong and on an upward trend. It has increased from 274.00 Cr. (Mar 2024) to 310.00 Cr., marking an increase of 36.00 Cr..
• For Total Assets, as of Mar 2025, the value is 763.00 Cr.. The value appears strong and on an upward trend. It has increased from 715.00 Cr. (Mar 2024) to 763.00 Cr., marking an increase of 48.00 Cr..

Notably, the Reserves (573.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Pudumjee Paper Products Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 10.09. This value is within the healthy range. It has decreased from 10.34 (Mar 24) to 10.09, marking a decrease of 0.25.
• For Diluted EPS (Rs.), as of Mar 25, the value is 10.09. This value is within the healthy range. It has decreased from 10.34 (Mar 24) to 10.09, marking a decrease of 0.25.
• For Cash EPS (Rs.), as of Mar 25, the value is 11.46. This value is within the healthy range. It has decreased from 11.67 (Mar 24) to 11.46, marking a decrease of 0.21.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.36. It has increased from 51.85 (Mar 24) to 61.36, marking an increase of 9.51.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.36. It has increased from 51.85 (Mar 24) to 61.36, marking an increase of 9.51.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.60.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 85.17. It has increased from 82.67 (Mar 24) to 85.17, marking an increase of 2.50.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 15.27. This value is within the healthy range. It has decreased from 15.74 (Mar 24) to 15.27, marking a decrease of 0.47.
• For PBIT / Share (Rs.), as of Mar 25, the value is 13.89. This value is within the healthy range. It has decreased from 14.40 (Mar 24) to 13.89, marking a decrease of 0.51.
• For PBT / Share (Rs.), as of Mar 25, the value is 13.55. This value is within the healthy range. It has decreased from 13.86 (Mar 24) to 13.55, marking a decrease of 0.31.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 10.08. This value is within the healthy range. It has decreased from 10.34 (Mar 24) to 10.08, marking a decrease of 0.26.
• For PBDIT Margin (%), as of Mar 25, the value is 17.92. This value is within the healthy range. It has decreased from 19.03 (Mar 24) to 17.92, marking a decrease of 1.11.
• For PBIT Margin (%), as of Mar 25, the value is 16.30. This value is within the healthy range. It has decreased from 17.42 (Mar 24) to 16.30, marking a decrease of 1.12.
• For PBT Margin (%), as of Mar 25, the value is 15.90. This value is within the healthy range. It has decreased from 16.77 (Mar 24) to 15.90, marking a decrease of 0.87.
• For Net Profit Margin (%), as of Mar 25, the value is 11.83. This value exceeds the healthy maximum of 10. It has decreased from 12.50 (Mar 24) to 11.83, marking a decrease of 0.67.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.42. This value is within the healthy range. It has decreased from 19.93 (Mar 24) to 16.42, marking a decrease of 3.51.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.62. This value is within the healthy range. It has decreased from 23.76 (Mar 24) to 19.62, marking a decrease of 4.14.
• For Return On Assets (%), as of Mar 25, the value is 12.54. This value is within the healthy range. It has decreased from 13.73 (Mar 24) to 12.54, marking a decrease of 1.19.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.09. It has decreased from 1.17 (Mar 24) to 1.09, marking a decrease of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 4.66. This value exceeds the healthy maximum of 3. It has increased from 2.87 (Mar 24) to 4.66, marking an increase of 1.79.
• For Quick Ratio (X), as of Mar 25, the value is 3.24. This value exceeds the healthy maximum of 2. It has increased from 1.82 (Mar 24) to 3.24, marking an increase of 1.42.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.21. This value is below the healthy minimum of 4. It has increased from 2.68 (Mar 24) to 3.21, marking an increase of 0.53.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.83 (Mar 24) to 0.00, marking a decrease of 4.83.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.28 (Mar 24) to 0.00, marking a decrease of 4.28.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.17 (Mar 24) to 0.00, marking a decrease of 95.17.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.72 (Mar 24) to 0.00, marking a decrease of 95.72.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 45.18. This value is within the healthy range. It has increased from 29.15 (Mar 24) to 45.18, marking an increase of 16.03.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 30.83. This value is within the healthy range. It has increased from 20.15 (Mar 24) to 30.83, marking an increase of 10.68.
• For Enterprise Value (Cr.), as of Mar 25, the value is 895.09. It has increased from 602.26 (Mar 24) to 895.09, marking an increase of 292.83.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.11. This value is within the healthy range. It has increased from 0.76 (Mar 24) to 1.11, marking an increase of 0.35.
• For EV / EBITDA (X), as of Mar 25, the value is 6.17. This value is within the healthy range. It has increased from 4.03 (Mar 24) to 6.17, marking an increase of 2.14.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.14. This value is within the healthy range. It has increased from 0.75 (Mar 24) to 1.14, marking an increase of 0.39.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 95.16 (Mar 24) to 0.00, marking a decrease of 95.16.
• For Price / BV (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has increased from 1.21 (Mar 24) to 1.59, marking an increase of 0.38.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.14. This value is within the healthy range. It has increased from 0.75 (Mar 24) to 1.14, marking an increase of 0.39.
• For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has decreased from 0.16 (Mar 24) to 0.10, marking a decrease of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness